Russia’s Sputnik V shows 82% efficacy against Delta strain — Italian researches
ROME, October 12. /TASS/: Russia’s Sputnik V COVID-19 vaccine demonstrates up to 82% efficacy against coronavirus variants, Andrea Antinori, director of the clinical research department at the National Institute for Infectious Diseases, which conducted the study on Sputnik V, told Italy’s Rai 3 TV channel late on Monday.
"Sputnik’s efficacy against [coronavirus] variants has been proved to be 82%. Compared with the 88% efficacy of Pfizer’s shot, it is not much lower. It is a high efficacy, at least against the Delta variant, which was proved by laboratory tests," he said.